Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ILiAD Appoints Former GSK Exec as Chief Business Officer | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

ILiAD Appoints Former GSK Exec as Chief Business Officer

Antony Blanc is a seasoned biopharmaceutical executive with experience in corporate strategy, vaccine development and commercialization, business development and partnering.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

ILiAD Biotechnologies Inc., an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, has appointed Antony Blanc, former VP, Head of Global Marketing and Global Strategic Pricing at GSK Vaccines, as Chief Business Officer (CBO).

Antony Blanc PhD is a seasoned biopharmaceutical executive with extensive experience in corporate strategy, vaccine development and commercialization, business development and partnering.

Experience

Prior to ILiAD, Blanc served as Chief Business and Commercial Officer at CureVac as well as various global commercial leadership positions at GSK Vaccines and in McKinsey’s European biotech practice. He brings a strong track record of building and executing growth strategies across clinical-stage and commercial organizations and will oversee ILiAD’s business development, commercial and long-term value creation initiatives.

“ILiAD has built a compelling platform with BPZE1 that has the potential to redefine pertussis vaccination and deliver meaningful public health benefit,” said Blanc. “I’m excited to join the team at this pivotal moment and help guide the Company’s strategic growth as it advances toward late-stage development and beyond.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics